Authors

The value of innovation in controlling myopia

How studies into myopia management can increase access to vision care.

Addressing higher order aberrations with wavefront guided scleral lenses in long-standing patients with keratoconus

Jamie Kuzniar, OD, FAAO, FSLS, shares key takeaways from a case series that investigated higher order aberration reduction in longstanding scleral lens wearers.

Does lifitegrast improve dry eye symptoms for contact lens wearers?

In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.

Navigating AI in optometry: A balancing act of innovation and ethics

How to be optimistic, responsible, and open in the face of new technology.

AAOpt 2024: How HEV-filtering soft contact lenses affect athletes' vision

In a study, a xenon slide illuminator was employed to mimic natural outdoor colors, allowing researchers to test brightness perception using a brightness-matching method, explains Billy R. Hammond.

Regeneron receives another CRL for its Eylea 8 mg

Regeneron faces another FDA setback for Eylea HD due to manufacturing issues, but plans for new facilities signal future production improvements.

Understanding blue light: Making sense of the spectrum

A new classification system helps patients reach informed decisions.

Atropine vs spectacles: Which move will be more powerful in the game of myopia management?

An official approval by the FDA in the United States can boost adoption rate of atropine and antimyopia glasses, which will change the landscape of myopia management.

South Korea's MFDS receives NDA for Tenpoint Therapeutics' Brimochol PF for presbyopia

The submission marks the first ex-US regulatory submission for Brimochol PF.

AAOpt 2025: Understanding recreational drug use and the eye

Young explores the complex relationship between recreational drug use and eye health, highlighting addiction's impact on vision and patient care strategies.

The power of pronouns: Caring for LGBTQ veteran patients in eye care

LGBTQ VA patients may miss appointments due to fear of discrimination

From discussion to decision: Educating patients on IOL expectations for better outcomes

AAOpt 2025: Comparing dry eye drops for patient comfort, adverse effects

Eric Schmidt, OD, FAAO, details a poster presentation given during AAOpt's Academy 2025 meeting.

Top-line DEWS III updates

A focus on driver-based treatment provides a broader clinical framework for smarter, more personalized dry eye care.

What will myopia control look like in 2034?

New long-term findings illuminate the future of DIMS spectacle lenses.

Regeneron receives another CRL for its Eylea 8 mg

Regeneron faces another FDA setback for Eylea HD due to manufacturing issues, but plans for new facilities signal future production improvements.

Aurion Biotech releases positive 12-month results from phase 1/2 CLARA trial

The trial evaluated the safety, efficacy, and tolerability of AURN001 in patients with corneal edema secondary to corneal endothelial dysfunction.

Finding the right fit as an LGBTQIA OD

Sometimes it takes several tries before settling into an inclusive practice that’s right for you.

AAOpt 2024: The vision and comfort performance of Infuse multifocal contact lenses

Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.

NOA Midwestern Symposium 2025: Knowing when to refer when post-trabeculectomy complications arise

Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.

What’s new with multifocal toric lenses?

Keylee Brown, OD, shares her experience with the Acuvue Oasys MAX 1-Day multifocal for astigmatism, which enhance comfort and vision for presbyopes with astigmatism.

SAHARA trial demonstrates sustained TearCare benefits for evaporative dry eye

New findings confirm TearCare's long-term effectiveness for dry eye disease, showing significant patient improvements with minimal treatments over 2 years.

AOA 2025: Innovation and education take forefront at Optometry's Meeting

ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.